148 related articles for article (PubMed ID: 16398469)
1. The molecular epidemiology of gliomas in adults.
Wrensch M; Fisher JL; Schwartzbaum JA; Bondy M; Berger M; Aldape KD
Neurosurg Focus; 2005 Nov; 19(5):E5. PubMed ID: 16398469
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and molecular pathology of glioma.
Schwartzbaum JA; Fisher JL; Aldape KD; Wrensch M
Nat Clin Pract Neurol; 2006 Sep; 2(9):494-503; quiz 1 p following 516. PubMed ID: 16932614
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of primary brain tumors: current concepts and review of the literature.
Wrensch M; Minn Y; Chew T; Bondy M; Berger MS
Neuro Oncol; 2002 Oct; 4(4):278-99. PubMed ID: 12356358
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
6. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Intracranial Gliomas.
Ostrom QT; Gittleman H; Stetson L; Virk S; Barnholtz-Sloan JS
Prog Neurol Surg; 2018; 30():1-11. PubMed ID: 29241168
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of gliomas.
Ostrom QT; Gittleman H; Stetson L; Virk SM; Barnholtz-Sloan JS
Cancer Treat Res; 2015; 163():1-14. PubMed ID: 25468222
[TBL] [Abstract][Full Text] [Related]
9. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
10. Molecular predictors of outcome in low-grade glioma.
Weiler M; Wick W
Curr Opin Neurol; 2012 Dec; 25(6):767-73. PubMed ID: 23160425
[TBL] [Abstract][Full Text] [Related]
11. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and etiology of gliomas.
Ohgaki H; Kleihues P
Acta Neuropathol; 2005 Jan; 109(1):93-108. PubMed ID: 15685439
[TBL] [Abstract][Full Text] [Related]
13. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Molecular Epidemiology.
Bauchet L; Ostrom QT
Neurosurg Clin N Am; 2019 Jan; 30(1):1-16. PubMed ID: 30470396
[TBL] [Abstract][Full Text] [Related]
15. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
16. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
17. The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking.
Andersson U; Degerman S; Dahlin AM; Wibom C; Johansson G; Bondy ML; Melin BS
Cancer Causes Control; 2019 Feb; 30(2):177-185. PubMed ID: 30560391
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anaplastic glioma.
Wick W; Wiestler B; Platten M
Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
[TBL] [Abstract][Full Text] [Related]
19. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
20. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls.
Wrensch M; Lee M; Miike R; Newman B; Barger G; Davis R; Wiencke J; Neuhaus J
Am J Epidemiol; 1997 Apr; 145(7):581-93. PubMed ID: 9098174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
